Condition

Mobility

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting1

Common interventions9

Lead sponsors shown4

Clinical trials

4 shown

Spinal Mobility, Rigidity, and Kinesiophobia in PD and TMDNCT07850674 · 2026-09-23

RECRUITING

Effects of Modified Otago Versus Action Observation on Strength, Mobility and Fall Risk in Diabetic NeuropathyNCT06459375 · 2024-05-01

COMPLETED

The Effects of Dual Task Training With Different Task Priorities on Physical Performance and Cognitive Status in Patients With Parkinson's DiseaseNCT06794177 · 2024-02-01

COMPLETED

Non-motor Symptoms, Balance, Muscle Strength, and Functional Mobility in Patients With Parkinson's DiseaseNCT04420910 · 2019-04-15

COMPLETED

Common interventions

Action Observation TrainingOTHER1 BalanceOTHER1 Fixed priority dual task trainingOTHER1 Functional mobilityOTHER1 Lower Limb StrengthOTHER1 modified otago exercisesOTHER1 Non-Motor SymptomsOTHER1 Single task trainingOTHER1 Variable priority dual task trainingOTHER1

Leading sponsors

Ankara Yildirim Beyazıt University 1 Hacettepe University 1 Mustafa Kemal University 1 Riphah International University 1

Trial status mix

COMPLETED3

RECRUITING1

Phase mix

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.